PALISADE BIO, INC. — Director's Dealing 2015

Nov 20, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2015-11-19

Reporting Person: GARR RICHARD (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-19	Common Stock	M	138122	$0.00	Acquired	1474243	Direct
2015-11-19	Common Stock	F	37776	$1.14	Disposed	1436467	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-19	Restricted Stock Unit	$	M	138122	Disposed		Common Stock (138122)	Direct

Footnotes

F1: Represents the conversion of restricted stock units into Common Stock. On November 19, 2015, the reporting person was granted 138,122 shares of Common Stock, of which 37,776 shares were forfeited for tax withholding purposes.

F2: Each restricted stock unit represents a right to receive one share of Neuralstem's Common Stock.